201 related articles for article (PubMed ID: 34176559)
1. Follicular lymphoma dynamics.
Milpied P; Gandhi AK; Cartron G; Pasqualucci L; Tarte K; Nadel B; Roulland S
Adv Immunol; 2021; 150():43-103. PubMed ID: 34176559
[TBL] [Abstract][Full Text] [Related]
2. Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm.
Laurent C; Dietrich S; Tarte K
Blood; 2024 Mar; 143(12):1080-1090. PubMed ID: 38096368
[TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma microenvironment: insights provided by single-cell analysis.
Abe Y
J Clin Exp Hematop; 2023 Sep; 63(3):143-151. PubMed ID: 37635086
[TBL] [Abstract][Full Text] [Related]
4. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
Matasar MJ; Luminari S; Barr PM; Barta SK; Danilov AV; Hill BT; Phillips TJ; Jerkeman M; Magagnoli M; Nastoupil LJ; Persky DO; Okosun J
Oncologist; 2019 Nov; 24(11):e1236-e1250. PubMed ID: 31346132
[TBL] [Abstract][Full Text] [Related]
5. Advances in the multi-omics landscape of follicular lymphoma.
Xu T; Zheng Z; Zhao W
Int J Biol Sci; 2023; 19(6):1955-1967. PubMed ID: 37063433
[TBL] [Abstract][Full Text] [Related]
6. The follicular lymphoma epigenome regulates its microenvironment.
Amin R; Braza MS
J Exp Clin Cancer Res; 2022 Jan; 41(1):21. PubMed ID: 35022084
[TBL] [Abstract][Full Text] [Related]
7. Unmet needs in the first-line treatment of follicular lymphoma.
Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR
Ann Oncol; 2017 Sep; 28(9):2094-2106. PubMed ID: 28430865
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
Kumar E; Pickard L; Okosun J
Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Dobaño-López C; Valero JG; Araujo-Ayala F; Nadeu F; Gava F; Faria C; Norlund M; Morin R; Bernes-Lasserre P; Arenas F; Grau M; López C; López-Oreja I; Serrat N; Martínez-Farran A; Hernández L; Playa-Albinyana H; Giménez R; Beà S; Campo E; Lagarde JM; López-Guillermo A; Magnano L; Colomer D; Bezombes C; Pérez-Galán P
Blood Cancer J; 2024 May; 14(1):75. PubMed ID: 38697976
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapy Approaches to Follicular Lymphoma.
Northend M; Townsend W
Drugs; 2021 Mar; 81(4):453-469. PubMed ID: 33616890
[TBL] [Abstract][Full Text] [Related]
11. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
Devan J; Janikova A; Mraz M
Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
[TBL] [Abstract][Full Text] [Related]
12. Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies.
Hanel W; Epperla N
J Hematol Oncol; 2021 Jun; 14(1):104. PubMed ID: 34193230
[TBL] [Abstract][Full Text] [Related]
13. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Kastenschmidt JM; Schroers-Martin JG; Sworder BJ; Sureshchandra S; Khodadoust MS; Liu CL; Olsen M; Kurtz DM; Diehn M; Wagar LE; Alizadeh AA
Cell Stem Cell; 2024 Mar; 31(3):410-420.e4. PubMed ID: 38402619
[TBL] [Abstract][Full Text] [Related]
14. B cell/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm.
Lamaison C; Tarte K
Immunol Rev; 2021 Jul; 302(1):273-285. PubMed ID: 34060097
[TBL] [Abstract][Full Text] [Related]
15. PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
Szumera-Ciećkiewicz A; Poleszczuk J; Kuczkiewicz-Siemion O; Paszkiewicz-Kozik E; Rymkiewicz G; Sokół K; Borysiuk A; Kotarska M; Kawecka M; Owczarek D; Pytlak B; Walewski J; Prochorec-Sobieszek M
Pathol Res Pract; 2020 Oct; 216(10):153096. PubMed ID: 32853965
[TBL] [Abstract][Full Text] [Related]
16. Novel acquisitions on biology and management of transformed follicular lymphoma.
Minoia C; Zucca E; Conconi A
Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
[TBL] [Abstract][Full Text] [Related]
17. Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet Needs.
Welaya K; Casulo C
Hematol Oncol Clin North Am; 2019 Aug; 33(4):627-638. PubMed ID: 31229159
[TBL] [Abstract][Full Text] [Related]
18. Dissecting follicular lymphoma: high versus low risk.
Smith SM
Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
[TBL] [Abstract][Full Text] [Related]
19. Upfront identification of high-risk follicular lymphoma.
Casulo C
Hematol Oncol; 2021 Jun; 39 Suppl 1():88-93. PubMed ID: 34105811
[TBL] [Abstract][Full Text] [Related]
20. Advances in Treatment of Follicular Lymphoma.
Luminari S; Trotman J; Federico M
Cancer J; 2020; 26(3):231-240. PubMed ID: 32496456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
